Despite the known skepticism of its leader Robert F Kennedy Jr, the Department of Health and Human Services quietly announced ...

More about IAVI's investigational Ebola Sudan vaccine candidate. In 2023, IAVI initiated a Phase 1 clinical trial of its rVSV-based Ebola Sudan vaccine candidate.

An effort to test several Ebola Sudan vaccines in Uganda in 2022 was abandoned because the outbreak was contained before the trial could be done. This time, years of planning to persuade countries ...

The US Department of Health and Human Services is weighing whether to fund new Marburg and Sudan Ebola virus vaccines even as Secretary Robert F. Kennedy Jr. overhauls the US immunization landscape, ...

The current Ebola Sudan Virus Disease outbreak has officially come to an end. This follows 42 days without a new case since the last confirmed patient was discharged on March 14 2025.

The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it infects cells. Currently, no approved treatments exist.

In a global first, Uganda’s Ministry of Health, the World Health Organization (WHO) and other partners today launched a first-ever clinical efficacy trial for a vaccine from Ebola from the Sudan ...

Ebola was discovered in 1976 in two simultaneous outbreaks in South Sudan and Congo, where it occurred in a village near the Ebola River, after which the disease is named. More about ...

In a first, scientists test the efficacy of an experimental vaccine against the life-threatening virus ...

This is Uganda's sixth outbreak of Ebola Sudan, which causes severe hemorrhagic fever disease with a case fatality rate of up to 50%. No licensed vaccines or therapeutics are available for Ebola ...